A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias
Clinical trial NCT06226571 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06226571
- Sponsor
- Syndax Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-21
- Primary completion
- 2027-02-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.